Zentalis Pharmaceuticals, Inc.
ZNTL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001725160
In the last 90 days, Zentalis Pharmaceuticals, Inc. insiders filed 1 open-market purchase and 0 sales; 114 institutions reported holding it in 13F filings for Q2 2026, worth $228.9M in total; no superinvestor holds it.
Superinvestors holding ZNTL, Q2 2026
No superinvestor reported holding ZNTL in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of ZNTL each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q3 2022
0 superinvestors holding at quarter end
- Sold out
- Viking Global Investors
Q1 2022
1 superinvestor holding at quarter end
- Reduced
- Viking Global Investors (−4.3%)
Q3 2021
1 superinvestor holding at quarter end
- Reduced
- Viking Global Investors (−11.7%)